1. Home
  2. CCEL vs CELU Comparison

CCEL vs CELU Comparison

Compare CCEL & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCEL
  • CELU
  • Stock Information
  • Founded
  • CCEL 1989
  • CELU 2016
  • Country
  • CCEL United States
  • CELU United States
  • Employees
  • CCEL N/A
  • CELU N/A
  • Industry
  • CCEL Managed Health Care
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCEL Health Care
  • CELU Health Care
  • Exchange
  • CCEL Nasdaq
  • CELU Nasdaq
  • Market Cap
  • CCEL 50.0M
  • CELU 50.4M
  • IPO Year
  • CCEL 1997
  • CELU N/A
  • Fundamental
  • Price
  • CCEL $7.71
  • CELU $1.68
  • Analyst Decision
  • CCEL
  • CELU
  • Analyst Count
  • CCEL 0
  • CELU 0
  • Target Price
  • CCEL N/A
  • CELU N/A
  • AVG Volume (30 Days)
  • CCEL 15.6K
  • CELU 182.6K
  • Earning Date
  • CCEL 04-14-2025
  • CELU 12-06-2024
  • Dividend Yield
  • CCEL 3.24%
  • CELU N/A
  • EPS Growth
  • CCEL N/A
  • CELU N/A
  • EPS
  • CCEL N/A
  • CELU N/A
  • Revenue
  • CCEL $31,838,476.00
  • CELU $48,200,000.00
  • Revenue This Year
  • CCEL $3.97
  • CELU N/A
  • Revenue Next Year
  • CCEL $0.91
  • CELU $233.89
  • P/E Ratio
  • CCEL N/A
  • CELU N/A
  • Revenue Growth
  • CCEL 1.95
  • CELU 225.94
  • 52 Week Low
  • CCEL $4.47
  • CELU $1.30
  • 52 Week High
  • CCEL $9.50
  • CELU $7.97
  • Technical
  • Relative Strength Index (RSI)
  • CCEL 48.98
  • CELU 37.21
  • Support Level
  • CCEL $7.26
  • CELU $1.85
  • Resistance Level
  • CCEL $8.20
  • CELU $2.18
  • Average True Range (ATR)
  • CCEL 0.54
  • CELU 0.26
  • MACD
  • CCEL -0.02
  • CELU -0.05
  • Stochastic Oscillator
  • CCEL 34.15
  • CELU 5.46

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

Share on Social Networks: